About the role
As SPV Therapeutics advances SPV374 toward the clinic, it needs a finance leader who can turn a scientific plan into a fundable, well-controlled operating plan. The Chief Financial Officer is a member of the executive team and a close partner to the CEO and the Board, with responsibility for financial planning, capital strategy, accounting and reporting, tax, treasury, risk and investor relations.
This is a hands-on role in a lean organization. The CFO will build the finance, procurement and reporting infrastructure that a clinical-stage company requires, and will help the company prepare for future public-market readiness.
Key responsibilities
Financial strategy and planning
- Develop the long-range financial plan, annual budget and cash-runway forecasts tied to clinical and CMC milestones.
- Model financing scenarios and recommend the timing, size and structure of equity, debt and non-dilutive capital.
Capital raising and investor relations
- Lead financing processes with the CEO, including materials, data-room preparation, diligence and negotiation.
- Manage relationships with existing and prospective investors, lenders and banking partners; support licensing and partnering transactions.
Accounting, controls and compliance
- Oversee GAAP accounting, month-end close, audit, tax (including R&D credits and transfer pricing) and treasury.
- Design and maintain internal controls, approval policies and vendor and CRO/CDMO contract governance.
- Prepare Board and committee reporting; support audit committee work and corporate governance.
Organization
- Build the finance team and systems; manage outside accountants, auditors and advisors.
- Partner with legal and the Corporate Secretary on corporate records, equity administration and regulatory filings.
Required qualifications
- 12+ years of progressive finance experience, including 5+ years in a senior finance leadership role in biotechnology, pharmaceuticals or life-sciences technology.
- Experience raising capital (venture, crossover, public offerings or strategic) and supporting M&A or licensing transactions.
- Strong command of U.S. GAAP, equity-compensation accounting, R&D accounting and clinical-trial cost accrual.
- Bachelor's degree in accounting, finance or a related field; CPA and/or MBA strongly preferred.
- Excellent communication skills and the ability to translate complex science and finance for diverse audiences.
Preferred qualifications
- Experience with SEC reporting, Sarbanes-Oxley readiness or an IPO.
- Familiarity with grants and non-dilutive funding, including SBIR/STTR.
- Experience in an international structure with Australian, Canadian or European entities.
Compensation & benefits
Compensation includes a competitive base salary, an annual performance bonus and an equity award. Benefits are expected to include medical, dental and vision coverage, a retirement plan and paid time off. Final terms are set by the Board of Directors on the CEO's recommendation.
Equal opportunity
SPV Therapeutics is an equal opportunity employer. We consider all qualified applicants without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, age, disability, veteran status, or any other characteristic protected by law. If you need an accommodation during the application process, please tell us in your application.